1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
2024) In Cardiovascular Revascularization Medicine(
- Contribution to journal › Article
- 2021
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
- 2020
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention : A SWEDEHEART study
(
- Contribution to journal › Article
- 2015
-
Mark
Improving outcomes in patients with coronary heart disease using national registers and platelet function testing
(
- Thesis › Doctoral thesis (compilation)